- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
Author: Scarlett Publish Time: 2025-02-07 Origin: Site
Dubai, UAE – As the Chinese New Year ushers in the Year of the Snake, leading IVD manufacturer Goldsite Diagnostics (hereinafter referred to as Goldsite) is making its presence at Medlab Middle East 2025, the region’s largest laboratory exhibition, held from February 3–6, 2025, in Dubai, showcasing the latest IVD innovations.
This year's Medlab coincides with the beginning of the Year of the Snake, a symbol of wisdom and transformation in traditional Chinese culture. The snake’s ability to shed its skin represents renewal and rebirth. Interestingly, the snake as a symbol of healing extends beyond Chinese culture. In Greek mythology, the Rod of Asclepius, entwined by a snake, has long been recognized as a symbol of medicine and healthcare. This meaningful coincidence aligns perfectly with Goldsite’s mission—continuously innovating to meet the evolving needs of healthcare, delivering high-quality, precise, and efficient diagnostic solutions to patients worldwide.
Medlab Middle East is the premier medical laboratory exhibition in the Middle East, bringing together industry experts, leading laboratory equipment manufacturers, and healthcare professionals from around the world. The 2025 edition is taking place at the Dubai World Trade Centre from February 3–6, featuring the latest advancements and innovations in laboratory medicine. The event provides an ideal platform for professionals to learn, network, and explore new business opportunities.
At Medlab 2025, Goldsite is showcasing a range of flagship diagnostic solutions, including:
Specific Protein Series
Aristo: A well-established diagnostic platform, with over 5,000 installations across major hospitals in China. Now enhanced with the FLC Free Light Chain assays to meet international market needs, this instrument has already been successfully installed in the Middle East and South America last year, gaining widespread customer recognition.
· GSH-60: A HPLC (High-performance liquid chromatography） HbA1c analyzer, ideal for medium to large healthcare institutions.
· A1c Go: A compact point-of-care (POCT) HbA1c analyzer, designed for small to mid-sized laboratories.
GSH-50: A newly launched cost-effective HPLC HbA1c analyzer offering high-throughput testing.
Goldsite’s HbA1c solutions have been successfully deployed across Europe, the Middle East, South America, Central Asia, and Southeast Asia, receiving positive customer feedback. Visitors to the booth have shown great anticipation for the newly introduced GSH-50 model.
At Medlab 2025, Goldsite is presenting a comprehensive range of diagnostic solutions to meet the needs of large hospitals, small clinics, and laboratories:
Flagship Specific Protein Analysis Platforms: GPP-100, Aristo
Diabetes HbA1c Management Solutions: GSH-60, GSH-50, A1c Go
New Launch – 3-Part Hematology Analyzer: GH-3100
Compact Benchtop Biochemistry Analyzer: GBA-1000
Fluorescence POCT (Point-of-Care Testing) Solution: FIA GO
Goldsite is committed to leveraging our 25+ years of in vitro diagnostic expertise to enhance the MENA region's diagnostic capabilities and healthcare services, contributing to the development of a robust global healthcare diagnostic supply chain.
As Medlab 2025 draws close, Goldsite extends heartfelt gratitude to all partners and visitors who joined us at our booth. We look forward to another year of collaboration—see you again in Dubai next year!
